CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-15 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −12,048 | $41.56 | $501K | 16,666 |
| 2025-12-15 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −6,000 | 0 | ||
| 2025-12-15 | Quart Barry D Director | Option exercise 10b5-1 | +20,129 | $10.36 | $209K | 32,675 |
| 2025-12-15 | Quart Barry D Director | Sale 10b5-1 | −20,129 | $41.51 | $836K | 12,546 |
| 2025-12-15 | Quart Barry D Director | Option exercise · Share Option 10b5-1 | −20,129 | 0 | ||
| 2025-12-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +16,164 | $11.10 | $179K | 47,250 |
| 2025-12-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +16,165 | $11.97 | $193K | 63,415 |
| 2025-12-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +10,512 | $10.76 | $113K | 73,927 |
| 2025-12-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −42,841 | $41.49 | $1.8M | 31,086 |
| 2025-12-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −16,164 | 5,388 | ||
| 2025-12-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −16,165 | 12,123 | ||
| 2025-12-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −10,512 | 14,016 | ||
| 2025-11-26 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +200 | $22.89 | $5K | 22,914 |
| 2025-11-26 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −200 | $42.89 | $9K | 22,714 |
| 2025-11-26 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −200 | 46,938 | ||
| 2025-11-17 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +6,500 | $8.83 | $57K | 35,184 |
| 2025-11-17 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −645 | $40.08 | $26K | 34,539 |
| 2025-11-17 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −11,825 | $41.30 | $488K | 22,714 |
| 2025-11-17 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −6,500 | 6,000 | ||
| 2025-11-13 | Patel Sanj K CHAIRMAN & CEO | Gift | −60,000 | 51,794 |
Page 19 of 74 · 1,467 trades